Recombinant Human G6PC Protein，His

G6PC, or glucose-6-phosphatase catalytic subunit, plays a crucial role in glucose homeostasis by facilitating the hydrolysis of glucose-6-phosphate to glucose and inorganic phosphate, a key step in gluconeogenesis and glycogenolysis. Its activity is predominantly found in the liver and kidneys, where it regulates blood sugar levels, making it essential for metabolic processes. Mutations in the G6PC gene can lead to various glycogen storage disorders, most notably Glycogen Storage Disease Type I (GSD-I), which is characterized by severe hypoglycemia, growth retardation, and hepatic complications. Given its significance in metabolic regulation and pathophysiology, research on G6PC recombinant proteins has gained traction. These studies aim to understand the structure-function relationship of G6PC, elucidate the molecular mechanisms underlying GSD-I, and explore therapeutic avenues. By generating recombinant G6PC proteins, scientists analyze enzyme kinetics, investigate potential small-molecule inhibitors, and establish models for drug testing. Additionally, understanding the detailed biochemical pathways involving G6PC can offer insights into broader metabolic disorders and pave the way for novel treatments, potentially improving the quality of life for patients with metabolic diseases. Thus, research on G6PC recombinant proteins is pivotal not only for basic biology but also for translational medicine, highlighting its potential impact on therapeutic strategies and understanding metabolic syndromes.